Inside the market strategies of today’s drugmakers Patent protection is expiring for multibillion-dollar medicines later this decade, forcing drugmakers to find new products and markets. From M&A strategies to emerging therapeutic areas, companies are reshaping their commercial approaches to sustain growth. INCLUDED IN THIS TRENDLINE Drug patents protect pharma profits. Track when they’ll expire. Lilly files six lawsuits in bid to shut down ‘black market’ for retatrutide Trump threatens tariffs on imported generic drugs
